首页 > 最新文献

Journal of Herbal Medicine最新文献

英文 中文
General Physicians’ Attitude and Decision-Making Towards Herbal Medicines Prescription: A Scenario-Based Cross-Sectional Study in Hamadan, Iran 伊朗哈马丹市全科医生对草药处方的态度和决策:一项基于情景的横断面研究
IF 2.3 4区 医学 Q1 Medicine Pub Date : 2024-01-09 DOI: 10.1016/j.hermed.2024.100844
R. Abedi , S. Moradkhani , G. Afsharmanesh , M. Rangchian

Introduction

Although general physicians (GPs) considerably affect herbal medicines (HMs) consumption, there is not enough insight into their attitude and behaviour towards prescribing HMs. This study investigated the GPs’ attitudes towards HMs, the relationship between their attitude and the general preference for HMs, and the effect of the following variables on their prescription decisions for HMs: (1) GP’s experience regarding the effectiveness of that HM, (2) access to the side effects information, (3) patient's payment capacity, and (4) patient’s attitude towards HMs.

Methods

A survey was conducted in Hamadan, Iran. GPs’ demographics, attitude, and decision towards prescribing HMs were asked. Data analysis included descriptive statistics, Kruskal-Wallis, logistic regression, and correlation.

Results

SSixty GPs’ data were analyzed. Their attitude was not very positive; only 16.6% often or always preferred HMs. The likelihood of prescribing HMs was increased by positive experiences with effectiveness (OR=11.2, p-value=0.000, CI: 5.2-24.4) and access to side effects information (OR=6.9, p-value=0.000, CI: 3.5-13.9). Affordability problems reduced the chance of HM prescription for mild (OR=1.8, p-value=0.012, CI: 1.1–2.9) and severe problems (OR=6.9, p-value=0.000, CI: 3.6–13.3). Patient’s positive opinion about HMs increased the probability of HMs prescription compared to neutral (OR=2.6, p-value= 0.002, CI: 1.4 – 4.8) and negative opinion (OR=9.4, p-value=0.000, CI: 4.1–21.3). No significant influence was observed for GP’s sex, age and experience. The model correctly predicted 80.89% of stated decisionss.

Conclusions

Enhancement of GPs and patients’ trust in HMs’ effectiveness and safety and improve these products’ affordability is suggested to increase HMs’ prescription by GPs.

引言 虽然全科医生(GPs)对中草药(HMs)的消费有相当大的影响,但对他们开具中草药处方的态度和行为却缺乏足够的了解。本研究调查了全科医生对草药的态度、他们的态度与对草药的普遍偏好之间的关系,以及以下变量对他们开具草药处方决定的影响:方法在伊朗哈马丹进行了一项调查。调查询问了全科医生的人口统计数据、对开具 HMs 处方的态度和决定。数据分析包括描述性统计、Kruskal-Wallis、逻辑回归和相关性分析。他们的态度并不积极,只有 16.6% 的人经常或总是喜欢使用 HMs。积极的疗效体验(OR=11.2,P 值=0.000,CI:5.2-24.4)和副作用信息的获取(OR=6.9,P 值=0.000,CI:3.5-13.9)增加了开具 HMs 处方的可能性。负担能力问题降低了轻度问题(OR=1.8,P 值=0.012,CI:1.1-2.9)和严重问题(OR=6.9,P 值=0.000,CI:3.6-13.3)处方 HM 的几率。与中立意见(OR=2.6,p-value= 0.002,CI:1.4 - 4.8)和消极意见(OR=9.4,p-value=0.000,CI:4.1-21.3)相比,患者对 HMs 的积极评价增加了处方 HMs 的概率。全科医生的性别、年龄和经验没有明显影响。结论 建议采取行动,增强全科医生和患者对 HMs 的有效性和安全性的信任,并提高这些产品的可负担性,以增加全科医生对 HMs 的处方量。
{"title":"General Physicians’ Attitude and Decision-Making Towards Herbal Medicines Prescription: A Scenario-Based Cross-Sectional Study in Hamadan, Iran","authors":"R. Abedi ,&nbsp;S. Moradkhani ,&nbsp;G. Afsharmanesh ,&nbsp;M. Rangchian","doi":"10.1016/j.hermed.2024.100844","DOIUrl":"10.1016/j.hermed.2024.100844","url":null,"abstract":"<div><h3>Introduction</h3><p>Although general physicians (<strong>GPs</strong>) considerably affect herbal medicines (<strong>HMs</strong>) consumption, there is not enough insight into their attitude and behaviour towards prescribing HMs. This study investigated the GPs’ attitudes towards HMs, the relationship between their attitude and the general preference for HMs, and the effect of the following variables on their prescription decisions for HMs: (1) GP’s experience regarding the effectiveness of that HM, (2) access to the side effects information, (3) patient's payment capacity, and (4) patient’s attitude towards HMs.</p></div><div><h3>Methods</h3><p>A survey was conducted in Hamadan, Iran. GPs’ demographics, attitude, and decision towards prescribing HMs were asked. Data analysis included descriptive statistics, Kruskal-Wallis, logistic regression, and correlation.</p></div><div><h3>Results</h3><p>SSixty GPs’ data were analyzed. Their attitude was not very positive; only 16.6% often or always preferred HMs. The likelihood of prescribing HMs was increased by positive experiences with effectiveness (OR=11.2, <em>p</em>-value=0.000, CI: 5.2-24.4) and access to side effects information (OR=6.9, <em>p</em>-value=0.000, CI: 3.5-13.9). Affordability problems reduced the chance of HM prescription for mild (OR=1.8, <em>p</em>-value=0.012, CI: 1.1–2.9) and severe problems (OR=6.9, <em>p</em>-value=0.000, CI: 3.6–13.3). Patient’s positive opinion about HMs increased the probability of HMs prescription compared to neutral (OR=2.6, <em>p</em>-value= 0.002, CI: 1.4 – 4.8) and negative opinion (OR=9.4, <em>p</em>-value=0.000, CI: 4.1–21.3). No significant influence was observed for GP’s sex, age and experience. The model correctly predicted 80.89% of stated decisionss.</p></div><div><h3>Conclusions</h3><p>Enhancement of GPs and patients’ trust in HMs’ effectiveness and safety and improve these products’ affordability is suggested to increase HMs’ prescription by GPs.</p></div>","PeriodicalId":56077,"journal":{"name":"Journal of Herbal Medicine","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139409609","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cycloisolongifolene-8,9-Dehydro-9-Formyl Inhibits Lipoxygenase and Might Play a Role in the Wound-Healing Property of Clerodendrum infortunatum and Tagetes erecta 环异龙脑-8,9-脱氢-9-醛基能抑制脂氧合酶,并可能在红花檵木和万寿菊的伤口愈合特性中发挥作用
IF 2.3 4区 医学 Q1 Medicine Pub Date : 2024-01-04 DOI: 10.1016/j.hermed.2023.100843
Bhavana Sampath Kumar, Sandra Ravi M, Junaiha Kapoor, Atheene Joy, Elcey C. Daniel, Shinomol George K, Deepu Joy Parayil, Dileep Francis

Introduction

Clerodendrum infortunatum, and Tagetes erecta, are frequently used in traditional medicinal systems like Ayurveda and Unani for their medicinal properties. This study explores their wound-healing potential.

Methods

Ethanol extracts were obtained from C infortunatum leaves and T erecta flowers and subjected to qualitative phytochemical analyses. . The antioxidant properties were assessed through 2,2-diphenyl-picrylhydrazyl (DPPH) and Ferric Reducing Antioxidant Power (FRAP) assays, both individually and combined. Cytotoxicity was tested using the MTT assay. An in vitro lipoxygenase (LOX) inhibition assay was used to evaluate anti-inflammatory activity. Extracts were further fractionated using silica gel column chromatography and assayed for LOX-inibition. Metabolite profiling of the active fractions were performed using GC-MS. Molecular docking was employed to study the interactions of the identified metabolites with LOX.

Results

The plant extracts exhibited substantial scavenging activity (76–80% in the DPPH assay). FRAP values were 415.31 µg ascorbic acid/g DW for C infortunatum and 1185.86 µg ascorbic acid/g DW for T erecta. The extracts and fractions showed moderate cytotoxicity, with the highest non-toxic concentration being 25 µg/mL. LOX inhibition was 54% for C infortunatum, and 56% for T erecta, comparable to vanillin (55%). Purified fractions achieved 70% (C infortunatum) and 76% (T erecta) inhibition. Proliferation assays revealed significant wound-healing activities of 76% (C infortunatum) and 90% (T erecta) at 25 µg/mL, compared to the control (50%). GC-MS identified the key metabolite, cycloisolongifolene-8,9-dehydro-9-formyl, in both fractions. Molecular docking provided mechanistic insights into LOX inhibition.

Conclusions

C infortunatum (leaf) and T erecta (flower) extracts possess remarkable wound-healing potential. The identified metabolite, cycloisolongifolene-8,9-dehydro-9-formyl, likely contributes to wound healing. The findings highlight the therapeutic potential of the plant extracts in wound management and warrant further investigation into the active principle/s involved in the mechanism.

引言 红花檵木(一种热带和亚热带灌木)和万寿菊(广泛分布于各大洲)因其愈合特性而被阿育吠陀和尤那尼等传统医学体系广泛使用。本研究探讨了它们的伤口愈合潜力。进行了初步的定性植物化学分析。通过 DPPH 和 FRAP 检测法评估了抗氧化特性,既包括单独的抗氧化特性,也包括综合的抗氧化特性。使用 MTT 试验测试了细胞毒性。体外脂氧合酶抑制试验测定了抗炎活性。根据脂氧合酶活性进行硅胶柱分馏。结果两种植物提取物都表现出很强的清除活性(在 DPPH 试验中为 76-80%)。C. infortunatum 的 FRAP 值为 415.31 µg 抗坏血酸/g DW,T. erecta 的 FRAP 值为 1185.86 µg 抗坏血酸/g DW。提取物和馏分显示出中等程度的细胞毒性,最高无毒浓度为 25 微克/毫升。对 C. infortunatum 和 T. erecta 的脂氧合酶抑制率分别为 54%和 56%,与香兰素(55%)相当。纯化馏分的抑制率分别为 70%(红椿)和 76%(直立椿)。增殖试验显示,与对照组(50%)相比,在 25 µg/ml 的浓度下,伤口愈合活性分别为 76%(银莲花)和 90%(直立花)。GC-MS 鉴定出两种馏分中的关键代谢物--环异龙葵烯 8,9-脱氢-9-甲酰基,分子对接支持脂氧合酶抑制作用。已确定的代谢产物环异龙脑烯 8,9-脱氢-9-甲酰基具有明显的脂氧合酶抑制作用,可能有助于加速伤口愈合。这些发现凸显了这些植物提取物在伤口管理方面的治疗潜力。
{"title":"Cycloisolongifolene-8,9-Dehydro-9-Formyl Inhibits Lipoxygenase and Might Play a Role in the Wound-Healing Property of Clerodendrum infortunatum and Tagetes erecta","authors":"Bhavana Sampath Kumar,&nbsp;Sandra Ravi M,&nbsp;Junaiha Kapoor,&nbsp;Atheene Joy,&nbsp;Elcey C. Daniel,&nbsp;Shinomol George K,&nbsp;Deepu Joy Parayil,&nbsp;Dileep Francis","doi":"10.1016/j.hermed.2023.100843","DOIUrl":"10.1016/j.hermed.2023.100843","url":null,"abstract":"<div><h3>Introduction</h3><p><span><em>Clerodendrum</em><em> infortunatum</em></span>, and <span><em>Tagetes erecta</em></span><span>, are frequently used in traditional medicinal systems like Ayurveda and Unani for their medicinal properties. This study explores their wound-healing potential.</span></p></div><div><h3>Methods</h3><p>Ethanol extracts were obtained from <em>C infortunatum</em> leaves and <em>T erecta</em><span> flowers and subjected to qualitative phytochemical<span> analyses. . The antioxidant properties were assessed through 2,2-diphenyl-picrylhydrazyl (DPPH) and Ferric Reducing Antioxidant Power (FRAP) assays, both individually and combined. Cytotoxicity was tested using the MTT assay. An i</span></span><em>n vitro</em><span> lipoxygenase (</span><strong>LOX)</strong><span><span> inhibition assay was used to evaluate anti-inflammatory activity. Extracts were further fractionated using silica gel<span> column chromatography and assayed for LOX-inibition. Metabolite profiling of the active fractions were performed using GC-MS. </span></span>Molecular docking was employed to study the interactions of the identified metabolites with LOX.</span></p></div><div><h3>Results</h3><p>The plant extracts exhibited substantial scavenging activity (76–80% in the DPPH assay). FRAP values were 415.31 µg ascorbic acid/g DW for <em>C infortunatum</em> and 1185.86 µg ascorbic acid/g DW for <em>T erecta</em>. The extracts and fractions showed moderate cytotoxicity, with the highest non-toxic concentration being 25 µg/mL. LOX inhibition was 54% for <em>C infortunatum</em>, and 56% for <em>T erecta</em><span>, comparable to vanillin (55%). Purified fractions achieved 70% (</span><em>C infortunatum</em>) and 76% (<em>T erecta</em>) inhibition. Proliferation assays revealed significant wound-healing activities of 76% (<em>C infortunatum)</em> and 90% (<em>T erecta</em>) at 25 µg/mL, compared to the control (50%). GC-MS identified the key metabolite, cycloisolongifolene-8,9-dehydro-9-formyl, in both fractions. Molecular docking provided mechanistic insights into LOX inhibition.</p></div><div><h3>Conclusions</h3><p><em>C infortunatum</em> (leaf) and <em>T erecta</em> (flower) extracts possess remarkable wound-healing potential. The identified metabolite, cycloisolongifolene-8,9-dehydro-9-formyl, likely contributes to wound healing. The findings highlight the therapeutic potential of the plant extracts in wound management and warrant further investigation into the active principle/s involved in the mechanism.</p></div>","PeriodicalId":56077,"journal":{"name":"Journal of Herbal Medicine","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139094305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Prospective, Controlled, Pilot Study of Personalised Add-on Ayurveda Treatment in High-Risk Type II Diabetes COVID-19 Patients 针对高风险 II 型糖尿病 COVID-19 患者的个性化附加阿育吠陀疗法前瞻性对照试验研究
IF 2.3 4区 医学 Q1 Medicine Pub Date : 2023-12-23 DOI: 10.1016/j.hermed.2023.100836
Somit Kumar , Sujith Subash Eranezhath , Vinod Kumar Vishwanathan , Mitravinda Sai Kakarla , Chaithanya Chenthamarakshan , Lakshmiprabha Selvaraj , Balagopal Satheeshan , Indulal Unniappan , Balaji Purushotham , Valdis Pīrāgs , Daniel Furst

Introduction

In hospitalised mild to moderate COVID-19 patients with pre-existing type 2 diabetes, we evaluated the efficacy of add-on customised Ayurveda intervention as compared to standard of care (SOC) in ameliorating symptoms, avoiding the need for ICU admission and ventilator support plus bringing down interleukin-6 (IL-6), and C-reactive protein (CRP) over 15 days.

Methods

In this quasi-experimental trial, 24 participants per arm diagnosed with COVID-19 by RT-PCR, aged 18–75 years, fulfilling the inclusion/exclusion criteria, were inducted. The subjects were allocated, depending on their own voluntary choice, to SOC plus Ayurveda (group 1) or SOC alone (group 2) for 15 days. The analyses used the Cochran-Mantel-Haenszel test, multivariate ANOVA plus within-group repeated measures ANOVA, and Cochran’s Q test.

Results

Of the 13 symptoms, cough (P = 0.04), general weakness (P = 0.02), and sore throat (P = 0.02) were statistically significantly different across the groups, with group I (add-on) improving better than group II (SOC). IL-6 dropped rapidly in group 1 by 7 days (P = 0.006) group 2 caught up by day 15 (P = 0.001). CRP improved slower than IL-6. The time to maximum change was not statistically different for IL-6 and CRP between the groups at day 15. There were no differences in random blood sugar and adverse events to Ayurveda-added SOC group.

Conclusions

In this quasi-experimental cough, weakness, and sore throat improved more in the add-on Ayurveda than in the SOC. IL-6 concentrations are declining more rapidly in the add-on Ayurveda. Clinical and laboratory adverse events suggested no additional toxicity of add-on Ayurveda treatments. This study supports the need for a randomised, double-blind trial.

方法在这项准实验性试验中,每组有 24 名通过 RT-PCR 诊断为 COVID-19 的患者,年龄在 18-75 岁之间,符合纳入/排除标准。根据受试者的自愿选择,他们被分配到 SOC 加阿育吠陀疗法(第 1 组)或单纯 SOC(第 2 组)治疗 15 天。分析采用了 Cochran-Mantel-Haenszel 检验、多变量方差分析、组内重复测量方差分析和 Cochran's Q 检验。结果 在 13 种症状中,咳嗽(p = 0.04)、全身乏力(p = 0.02)和咽喉痛(p = 0.02)在各组之间存在显著的统计学差异,第一组(附加组)的改善程度优于第二组(SOC 组)。第一组的 IL-6 在 7 天内迅速下降(p=0.006),第二组则在第 15 天赶上(p=0.001)。CRP 的改善速度慢于 IL-6。在第 15 天时,IL-6 和 CRP 的最大变化时间在各组之间没有统计学差异。结论 在这项探索性试点研究中,阿育吠陀外用药组的咳嗽、乏力和咽喉痛的改善程度高于阿育吠陀外用药组。添加 Ayurveda 的 IL-6 浓度下降得更快。临床和实验室AEs表明,附加Ayurveda疗法没有额外的毒性。这项研究支持了进行随机双盲试验的必要性。
{"title":"A Prospective, Controlled, Pilot Study of Personalised Add-on Ayurveda Treatment in High-Risk Type II Diabetes COVID-19 Patients","authors":"Somit Kumar ,&nbsp;Sujith Subash Eranezhath ,&nbsp;Vinod Kumar Vishwanathan ,&nbsp;Mitravinda Sai Kakarla ,&nbsp;Chaithanya Chenthamarakshan ,&nbsp;Lakshmiprabha Selvaraj ,&nbsp;Balagopal Satheeshan ,&nbsp;Indulal Unniappan ,&nbsp;Balaji Purushotham ,&nbsp;Valdis Pīrāgs ,&nbsp;Daniel Furst","doi":"10.1016/j.hermed.2023.100836","DOIUrl":"10.1016/j.hermed.2023.100836","url":null,"abstract":"<div><h3>Introduction</h3><p>In hospitalised mild to moderate COVID-19 patients with pre-existing type 2 diabetes, we evaluated the efficacy of add-on customised Ayurveda intervention as compared to standard of care (<strong>SOC</strong>) in ameliorating symptoms, avoiding the need for ICU admission and ventilator support plus bringing down interleukin-6 (<strong>IL-6</strong>), and C-reactive protein (<strong>CRP</strong>) over 15 days.</p></div><div><h3>Methods</h3><p>In this quasi-experimental trial, 24 participants per arm diagnosed with COVID-19 by RT-PCR, aged 18–75 years, fulfilling the inclusion/exclusion criteria, were inducted. The subjects were allocated, depending on their own voluntary choice, to SOC plus Ayurveda (group 1) or SOC alone (group 2) for 15 days. The analyses used the Cochran-Mantel-Haenszel test, multivariate ANOVA plus within-group repeated measures ANOVA, and Cochran’s Q test.</p></div><div><h3>Results</h3><p>Of the 13 symptoms, cough (<em>P</em> = 0.04), general weakness (<em>P</em> = 0.02), and sore throat (<em>P</em> = 0.02) were statistically significantly different across the groups, with group I (add-on) improving better than group II (SOC). IL-6 dropped rapidly in group 1 by 7 days (<em>P</em> = 0.006) group 2 caught up by day 15 (<em>P</em> = 0.001). CRP improved slower than IL-6. The time to maximum change was not statistically different for IL-6 and CRP between the groups at day 15. There were no differences in random blood sugar and adverse events to Ayurveda-added SOC group.</p></div><div><h3>Conclusions</h3><p>In this quasi-experimental cough, weakness, and sore throat improved more in the add-on Ayurveda than in the SOC. IL-6 concentrations are declining more rapidly in the add-on Ayurveda. Clinical and laboratory adverse events suggested no additional toxicity of add-on Ayurveda treatments. This study supports the need for a randomised, double-blind trial.</p></div>","PeriodicalId":56077,"journal":{"name":"Journal of Herbal Medicine","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2023-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2210803323002142/pdfft?md5=bb8795c8ac75b936f49e979c16531263&pid=1-s2.0-S2210803323002142-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139022550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Leishmanicidal Activity of Moringa oleifera (L.) Leaf Protein Extract on the Indian Strain of Leishmania donovani: An In Vitro Study Moringa oleifera(L. )叶蛋白提取物对印度唐氏利什曼病菌株的利什曼杀灭活性:体外研究
IF 2.3 4区 医学 Q1 Medicine Pub Date : 2023-12-22 DOI: 10.1016/j.hermed.2023.100832
P. Devgupta, P.K. Pramanik, D Roy Chowdhury, P. Ghosh, T. Chakraborti

Introduction

Recurring incidents of drug resistance and the health hazards associated with the chemotherapeutic treatment of visceral leishmaniasis necessitate the search for safer yet equally effective biologically available alternate therapeutics. Plant products are being emphasised in this regard. Thus, Moringa oleifera leaf was chosen here, and an in vitro study was undertaken to determine its antileishmanial activity against visceral leishmaniasis.

Methods

The protein in M. oleifera leaf extract (Mo-EX) was identified by denaturing polyacrylamide gel electrophoresis. The antipromastigote activity and cytotoxicity of the proteinaceous Mo-EX were determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay. Phase contrast microscopy and scanning electron microscopy analyses confirmed the morphological alterations of the promastigotes. The anti-amastigote activity of Mo-EX was determined by microscopic intracellular counting. Apoptosis, reactive oxygen species (ROS) generation, and thiol depletion were assessed by flow cytometric analysis, and nitric oxide production was determined by colorimetric assays.

Results

M. oleifera leaf extract displayed 50% inhibitory concentration valuesagainst Leishmania donovani promastigotes and intracellular amastigotes of 11.85 ± 0.08 and 8.86 ± 0.03 μg/ml, respectively, with a 50% lethal concentration in RAW 264.7 macrophages of 2 036.25 ± 0.04 μg/ml. Mo-EX reduced thiol production, significantly increased ROS generation, and induced apoptosis in L. donovani promastigotes while altering their morphology. Mo-EX evoked ROS and nitric oxide generation in parasite-infected host cells ex vivo.

Conclusions

The findings of the present study elucidate the leishmanicidal activity of protein-rich Mo-EX in L. donovani (MHOM/IN/1983/AG83) promastigotes and amastigotes, and Mo-EX was found to be moderately safe in RAW 264.7 host macrophages in vitro.

背景由于内脏利什曼病(VL)的化学疗法经常出现耐药性并对健康造成危害,因此有必要寻找更安全但同样有效的生物替代疗法。在这方面,植物产品受到重视。方法通过变性聚丙烯酰胺凝胶电泳对油辣木叶提取物(Mo-EX)中的蛋白质进行鉴定。通过 3-(4,5-二甲基噻唑-2-基)-2,5-二苯基溴化四氮唑(MTT)试验测定了含蛋白的 Mo-EX 的抗原生动物活性和细胞毒性。相差显微镜(PCM)和扫描电子显微镜(SEM)分析证实了原虫的形态改变。通过显微细胞内计数确定了 Mo-EX 的抗原生动物活性。通过流式细胞分析评估了细胞凋亡、活性氧(ROS)生成和硫醇耗竭,并通过比色法测定了一氧化氮(NO)生成。结果 Mo-EX对唐氏利什曼原虫和细胞内非原虫的50%抑制浓度(IC50)值分别为11.85±0.08 µg/ml和8.86±0.03 μg/ml,在RAW 264.7巨噬细胞中的50%致死浓度(LC50)为2036.25±0.04 μg/ml。Mo-EX 可减少硫醇的产生,显著增加 ROS 的生成,并诱导唐诺沃尼原虫凋亡,同时改变其形态。结论本研究结果阐明了富含蛋白质的 Mo-EX 对唐诺沃尼原虫(MHOM/IN/1983/AG83)原生体和非原生体的杀利什曼活性,并发现 Mo-EX 在体外对 RAW 264.7 宿主巨噬细胞具有适度的安全性。
{"title":"Leishmanicidal Activity of Moringa oleifera (L.) Leaf Protein Extract on the Indian Strain of Leishmania donovani: An In Vitro Study","authors":"P. Devgupta,&nbsp;P.K. Pramanik,&nbsp;D Roy Chowdhury,&nbsp;P. Ghosh,&nbsp;T. Chakraborti","doi":"10.1016/j.hermed.2023.100832","DOIUrl":"10.1016/j.hermed.2023.100832","url":null,"abstract":"<div><h3>Introduction</h3><p><span>Recurring incidents of drug resistance and the health hazards associated with the chemotherapeutic treatment<span> of visceral leishmaniasis necessitate the search for safer yet equally effective biologically available alternate therapeutics. Plant products are being emphasised in this regard. Thus, </span></span><span><em>Moringa oleifera</em></span> leaf was chosen here, and an <em>in vitro</em> study was undertaken to determine its antileishmanial activity against visceral leishmaniasis.</p></div><div><h3>Methods</h3><p>The protein in <em>M. oleifera</em> leaf extract (<strong>Mo-EX</strong><span><span>) was identified by denaturing polyacrylamide gel electrophoresis. The antipromastigote activity and cytotoxicity of the proteinaceous Mo-EX were determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay. Phase contrast microscopy<span> and scanning electron microscopy analyses confirmed the morphological alterations of the </span></span>promastigotes<span>. The anti-amastigote activity of Mo-EX was determined by microscopic intracellular counting. Apoptosis<span>, reactive oxygen species (</span></span></span><strong>ROS</strong><span><span>) generation, and thiol depletion were assessed by flow cytometric analysis, and nitric oxide production was determined by </span>colorimetric assays.</span></p></div><div><h3>Results</h3><p><em>M. oleifera</em> leaf extract displayed 50% inhibitory concentration valuesagainst <span><em>Leishmania donovani</em></span> promastigotes and intracellular amastigotes of 11.85 ± 0.08 and 8.86 ± 0.03 μg/ml, respectively, with a 50% lethal concentration in RAW 264.7 macrophages of 2 036.25 ± 0.04 μg/ml. Mo-EX reduced thiol production, significantly increased ROS generation, and induced apoptosis in <em>L. donovani</em> promastigotes while altering their morphology. Mo-EX evoked ROS and nitric oxide generation in parasite-infected host cells <span><em>ex vivo</em></span>.</p></div><div><h3>Conclusions</h3><p>The findings of the present study elucidate the leishmanicidal activity of protein-rich Mo-EX in <em>L. donovani</em> (MHOM/IN/1983/AG83) promastigotes and amastigotes, and Mo-EX was found to be moderately safe in RAW 264.7 host macrophages <em>in vitro.</em></p></div>","PeriodicalId":56077,"journal":{"name":"Journal of Herbal Medicine","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2023-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139022504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative evaluation of the efficacy of Achyranthes aspera gel with tetracycline fibres in managing periodontitis: a single-blind, randomised clinical study 牛膝凝胶与四环素纤维治疗牙周炎疗效的比较评估:单盲随机临床研究
IF 2.3 4区 医学 Q1 Medicine Pub Date : 2023-12-20 DOI: 10.1016/j.hermed.2023.100842
Tania D’cruz , Vandana Panda , Mala Dixit , Geetika Prabhakar , Nikita Patil

Introduction

The present study formulates, evaluates, and compares a gel made from Achyranthes aspera root extract (AAE) with tetracycline fibers for its protective effect in patients suffering from chronic periodontitis.

Methods

The AAE gel was evaluated for various physicochemical parameters, in vitro permeability, and stability, and the active phytoconstituent rutin was quantified in AAE by high performance thin layer chromatography (HPTLC). Patients (20-60 years) suffering from chronic periodontitis with a probing pocket depth (PPD) of 5-7 mm and no systemic diseases were divided into 2 groups (20 each) and treated with scaling and root planing (SRP) followed by subgingival placement of the herbal gel or tetracycline fibers (standard). Plaque Index (PI), Gingival Index (GI), Pocket Probing Depth (PPD), and Clinical Attachment Level (CAL) were recorded at baseline and after 3 months. The student’s t-test was used for statistical analysis.

Results

The AAE gel was found to be stable for 2 months, and the content of rutin was found to be 0.76µg in 100mg of AAE. A significant reduction in the periodontal disease parameters was observed in the standard and gel-treated groups between their baseline and 3-month interval values. The herbal gel treatment was comparable to tetracycline treatment in significantly attenuating the periodontitis-elevated PI, GI PPD, and CAL levels.

Conclusion

The amelioration of periodontitis and gingival inflammation by the AAE gel may be attributed to the potent antioxidant and anti-inflammatory activity of its phytoconstituents. AAE gel may thus be used as a safe adjunct to SRP in chronic periodontitis. CTRI/2018/09/015621 [Registered on: 06/09/2018]

导言:牛膝是一种遍布全球的热带植物,据体外和临床研究报告,牛膝具有抗菌、消炎和抗氧化作用,对牙周炎有一定的疗效。本研究对牛膝根提取物(AAE)与四环素纤维制成的凝胶进行了配制、评估和比较,以确定其对慢性牙周炎患者的保护作用。方法对 AAE 凝胶的各种理化参数、体外渗透性和稳定性进行了评估,并通过 HPTLC 对 AAE 中的活性植物成分芦丁进行了定量。将探诊袋深度为 5-7 毫米、无全身性疾病的慢性牙周炎患者(20-60 岁)分为两组,每组 20 人,先进行洗牙和根面平整(SRP),然后在龈下放置中药凝胶或四环素纤维(标准)。在基线和 3 个月后记录牙菌斑指数 (PI)、牙龈指数 (GI)、探诊窝深度 (PPD) 和临床附着水平 (CAL)。结果发现 AAE 凝胶在 2 个月内保持稳定,100 毫克 AAE 中芦丁的含量为 0.76 微克。标准组和凝胶治疗组的牙周病参数在基线值和 3 个月间隔值之间有明显下降。在显著降低牙周炎升高的 PI、GI PPD 和 CAL 水平方面,草药凝胶治疗与四环素治疗效果相当。因此,AAE凝胶可作为SRP的一种安全辅助治疗慢性牙周炎的药物。
{"title":"Comparative evaluation of the efficacy of Achyranthes aspera gel with tetracycline fibres in managing periodontitis: a single-blind, randomised clinical study","authors":"Tania D’cruz ,&nbsp;Vandana Panda ,&nbsp;Mala Dixit ,&nbsp;Geetika Prabhakar ,&nbsp;Nikita Patil","doi":"10.1016/j.hermed.2023.100842","DOIUrl":"10.1016/j.hermed.2023.100842","url":null,"abstract":"<div><h3>Introduction</h3><p>The present study formulates, evaluates, and compares a gel made from <span><em>Achyranthes aspera</em></span><span><span> root extract (AAE) with tetracycline fibers for its protective effect </span>in patients<span> suffering from chronic periodontitis.</span></span></p></div><div><h3>Methods</h3><p>The AAE gel was evaluated for various physicochemical parameters, <em>in vitro</em><span><span> permeability, and stability, and the active phytoconstituent rutin<span> was quantified in AAE by high performance thin layer chromatography (HPTLC). Patients (20-60 years) suffering from chronic </span></span>periodontitis<span> with a probing pocket depth (PPD) of 5-7 mm and no systemic diseases<span><span> were divided into 2 groups (20 each) and treated with scaling and root planing (SRP) followed by subgingival placement of the herbal gel or tetracycline fibers (standard). </span>Plaque Index<span> (PI), Gingival Index (GI), Pocket Probing Depth (PPD), and Clinical Attachment Level (CAL) were recorded at baseline and after 3 months. The student’s t-test was used for statistical analysis.</span></span></span></span></p></div><div><h3>Results</h3><p><span>The AAE gel was found to be stable for 2 months, and the content of rutin was found to be 0.76µg in 100mg of AAE. A significant reduction in the periodontal disease parameters was observed in the standard and gel-treated groups between their baseline and 3-month interval values. The herbal gel </span>treatment was comparable to tetracycline treatment in significantly attenuating the periodontitis-elevated PI, GI PPD, and CAL levels.</p></div><div><h3>Conclusion</h3><p>The amelioration of periodontitis and gingival inflammation by the AAE gel may be attributed to the potent antioxidant and anti-inflammatory activity of its phytoconstituents. AAE gel may thus be used as a safe adjunct to SRP in chronic periodontitis. CTRI/2018/09/015621 [Registered on: 06/09/2018]</p></div>","PeriodicalId":56077,"journal":{"name":"Journal of Herbal Medicine","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2023-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138820970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical research hotspots and trends of atherosclerosis treatment with traditional Chinese medicine preparations 中药制剂治疗动脉粥样硬化的临床研究热点与趋势
IF 2.3 4区 医学 Q1 Medicine Pub Date : 2023-12-20 DOI: 10.1016/j.hermed.2023.100839
Jingyi Li, Jiao Wu, Xiaohu Xue, Jianhe Fang, Jingjing Li, Meiying Ao

Introduction

While traditional Chinese medicine (TCM) has proved to be effective in treating atherosclerosis (AS), further analyses of the current research trends and treatment quality are essential. Based on data and visualisation analyses, this study aimed to explore the research hotspots and trends of AS treatment with TCM.

Methods

Relevant literature was searched using the evidence-based strategy system. Visual cluster analysis, association rule analysis, and study quality evaluation were performed using VOSviewer, IBM SPSS Statistics 23, Cochrane Risk Bias Assessment Scale, and Modified Jadad Scale.

Results

A total of 334 eligible papers were included. Over the past decade, the number of annual publications in this field has substantially increased, with a shift towards combining Chinese and Western medicine and using standardised and detailed outcome indicators. The frequently used herbs have warm or cold nature, sweet or bitter flavour, and belong to the liver, lung, or spleen channel. Salvia miltiorrhiza Bunge (Danshen) - Astragalus mongholicus Bunge (Huangqi) + Conioselinum anthriscoides 'Chuanxiong' (Chuanxiong) was the most commonly used combination, while Carthamus tinctorius L. (Honghua) - Prunus persica (L.) Batsch (Taoren) + Chuanxiong was associated with the highest confidence. The protocols of studies with a high risk of bias lacked standardisation, and the administration protocols of different clinical studies that used the same TCM preparations showed significant diversification. Despite this, the literature quality has shown pronounced growth in recent years.

Conclusions

Clinical research on AS prevention and treatment using TCM preparations is popular and follows TCM pathology theory; however, the overall research quality needs further improvement.

引言 虽然传统中医药(TCM)已被证明能有效治疗动脉粥样硬化(AS),但进一步分析当前的研究趋势和治疗质量是非常必要的。本研究以数据和可视化分析为基础,旨在探讨中医药治疗动脉粥样硬化的研究热点和趋势。采用 VOSviewer、IBM SPSS Statistics 23、Cochrane Risk Bias Assessment Scale 和 Modified Jadad Scale 进行可视化聚类分析、关联规则分析和研究质量评价。在过去十年中,该领域每年发表的论文数量大幅增加,并向中西医结合和使用标准化详细结果指标的方向转变。常用的药材性味寒温、甘苦,归肝、肺、脾经。丹参(丹参)-黄芪(黄芪)+川芎(川芎)是最常用的组合,而桔梗(红花)-桃仁(桃仁)+川芎的可信度最高。偏倚风险较高的研究方案缺乏标准化,而使用相同中药制剂的不同临床研究的给药方案呈现出明显的多样性。结论使用中药制剂预防和治疗强直性脊柱炎的临床研究遵循中医病理理论,很受欢迎,但整体研究质量有待进一步提高。
{"title":"Clinical research hotspots and trends of atherosclerosis treatment with traditional Chinese medicine preparations","authors":"Jingyi Li,&nbsp;Jiao Wu,&nbsp;Xiaohu Xue,&nbsp;Jianhe Fang,&nbsp;Jingjing Li,&nbsp;Meiying Ao","doi":"10.1016/j.hermed.2023.100839","DOIUrl":"10.1016/j.hermed.2023.100839","url":null,"abstract":"<div><h3>Introduction</h3><p><span>While traditional Chinese medicine (TCM) has proved to be effective in treating </span>atherosclerosis<span> (AS), further analyses of the current research trends and treatment quality are essential. Based on data and visualisation analyses, this study aimed to explore the research hotspots and trends of AS treatment with TCM.</span></p></div><div><h3>Methods</h3><p>Relevant literature was searched using the evidence-based strategy system. Visual cluster analysis, association rule analysis, and study quality evaluation were performed using VOSviewer, IBM SPSS Statistics 23, Cochrane Risk Bias Assessment Scale, and Modified Jadad Scale.</p></div><div><h3>Results</h3><p>A total of 334 eligible papers were included. Over the past decade, the number of annual publications in this field has substantially increased, with a shift towards combining Chinese and Western medicine and using standardised and detailed outcome indicators. The frequently used herbs have warm or cold nature, sweet or bitter flavour, and belong to the liver, lung, or spleen channel. <span><em>Salvia miltiorrhiza</em></span> Bunge (Danshen) - <span><em>Astragalus</em><em> mongholicus</em></span> Bunge (Huangqi) + <em>Conioselinum anthriscoides</em> 'Chuanxiong' (Chuanxiong) was the most commonly used combination, while <span><em>Carthamus tinctorius</em></span> L. (Honghua) - <em>Prunus persica</em> (L.) Batsch (Taoren) + Chuanxiong was associated with the highest confidence. The protocols of studies with a high risk of bias lacked standardisation, and the administration protocols of different clinical studies that used the same TCM preparations showed significant diversification. Despite this, the literature quality has shown pronounced growth in recent years.</p></div><div><h3>Conclusions</h3><p>Clinical research on AS prevention and treatment using TCM preparations is popular and follows TCM pathology theory; however, the overall research quality needs further improvement.</p></div>","PeriodicalId":56077,"journal":{"name":"Journal of Herbal Medicine","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2023-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138993938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Lantana camara Ethanolic Leaf Extract on Survival and Migration of MDA-MB-231 Triple-Negative Breast Cancer Cell Line 香蒲乙醇叶提取物对 MDA-MB-231 三阴性乳腺癌细胞株存活和迁移的影响
IF 2.3 4区 医学 Q1 Medicine Pub Date : 2023-12-20 DOI: 10.1016/j.hermed.2023.100837
A. Pal , S. Sanyal , S. Das, T.K. Sengupta

Introduction

Breast cancer is a leading cause of cancer-related death worldwide. Lantana camara has been reported to cure a number of ailments, with few studies showing its cytotoxic effects on breast cancer cells. However, the impact of L. camara on triple-negative breast cancer cells is largely obscure to date. The present study investigated the effect of ethanolic extract of L. camara leaves on the triple-negative breast cancer cell line, MDA-MB-231.

Methods

Cytotoxic effect of the extract on the cells was determined by cell survival assay. Cell-cycle phase distribution was analysed using flow cytometry. To study the effect on nuclear morphology, nuclear-stained cells were visualised using epifluorescence microscopy. The induction of apoptosis and generation of reactive oxygen species were conducted using flow cytometry. Cellular migration was studied by performing wound healing assay. Real-time polymerase chain reaction was done to determine the mRNA levels of some key genes.

Results

L. camara leaf extract induced cytomorphological changes and growth-inhibitory effect on MDA-MB-231 cells in a dose-dependent manner. The extract also induced G0/G1 cell-cycle arrest and nuclear condensation. Flow cytometry analysis confirmed cell death by apoptosis. L. camara leaf extract also reduced the migration of MDA-MB-231 cells. mRNA expression levels also supported the above observations.

Conclusions

This study demonstrates the efficacy of the extract to induce growth-inhibitory and antimigratory effects on MDA-MB-231 cells. Our results thus suggest that L. camara leaf extract can be considered as a potent source of chemotherapeutic agents for triple-negative breast cancer.

导言乳腺癌是全球癌症相关死亡的主要原因。据报道,香根草可治疗多种疾病,但很少有研究显示它对乳腺癌细胞有细胞毒性作用。然而,迄今为止,香根草对三阴性乳腺癌细胞的影响还很模糊。本研究调查了香茶菜叶乙醇提取物对三阴性乳腺癌细胞系 MDA-MB-231 的影响。使用流式细胞仪分析细胞周期的阶段分布。为了研究对细胞核形态的影响,使用外荧光显微镜观察细胞核染色。使用流式细胞仪检测细胞凋亡的诱导和活性氧的生成。通过伤口愈合试验研究细胞迁移。实时聚合酶链反应测定了一些关键基因的 mRNA 水平。该提取物还能诱导 G0/G1 细胞周期停滞和核凝聚。流式细胞仪分析证实了细胞凋亡。MDA-MB-231 细胞的 mRNA 表达水平也支持上述观察结果。因此,我们的研究结果表明,香蒲叶提取物可被视为治疗三阴性乳腺癌的有效化疗药物。
{"title":"Effect of Lantana camara Ethanolic Leaf Extract on Survival and Migration of MDA-MB-231 Triple-Negative Breast Cancer Cell Line","authors":"A. Pal ,&nbsp;S. Sanyal ,&nbsp;S. Das,&nbsp;T.K. Sengupta","doi":"10.1016/j.hermed.2023.100837","DOIUrl":"10.1016/j.hermed.2023.100837","url":null,"abstract":"<div><h3>Introduction</h3><p>Breast cancer is a leading cause of cancer-related death worldwide. <span><em>Lantana camara</em></span><span><span> has been reported to cure a number of ailments, with few studies showing its cytotoxic effects on breast </span>cancer cells. However, the impact of </span><em>L. camara</em> on triple-negative breast cancer cells is largely obscure to date. The present study investigated the effect of ethanolic extract of <em>L. camara</em> leaves on the triple-negative breast cancer cell line, MDA-MB-231.</p></div><div><h3>Methods</h3><p><span>Cytotoxic effect of the extract on the cells was determined by cell survival assay. Cell-cycle phase distribution was analysed using flow cytometry. To study the effect on nuclear morphology, nuclear-stained cells were visualised using epifluorescence microscopy. The induction of </span>apoptosis<span> and generation of reactive oxygen species<span> were conducted using flow cytometry. Cellular migration was studied by performing wound healing assay. Real-time polymerase chain reaction was done to determine the mRNA levels of some key genes.</span></span></p></div><div><h3>Results</h3><p><em>L. camara</em> leaf extract induced cytomorphological changes and growth-inhibitory effect on MDA-MB-231 cells in a dose-dependent manner. The extract also induced G0/G1 cell-cycle arrest and nuclear condensation. Flow cytometry analysis confirmed cell death by apoptosis. <em>L. camara</em><span> leaf extract also reduced the migration of MDA-MB-231 cells. mRNA expression levels also supported the above observations.</span></p></div><div><h3>Conclusions</h3><p>This study demonstrates the efficacy of the extract to induce growth-inhibitory and antimigratory effects on MDA-MB-231 cells. Our results thus suggest that <em>L. camara</em> leaf extract can be considered as a potent source of chemotherapeutic agents for triple-negative breast cancer.</p></div>","PeriodicalId":56077,"journal":{"name":"Journal of Herbal Medicine","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2023-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139022355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Scrophularia striata hydroalcoholic extract on differentiation of human adipose-derived mesenchymal stem cells into chondrocytes and osteocytes 条纹草水醇提取物对人脂肪间充质干细胞(hADSCs)分化为软骨细胞和骨细胞的影响
IF 2.3 4区 医学 Q1 Medicine Pub Date : 2023-12-20 DOI: 10.1016/j.hermed.2023.100841
Zahra Bagheri-Hosseinabadi , Fatemeh Javani Jouni , Jaber Zafari , Saba Sadeghi , Mitra Abbasifard

Introduction

Osteoarthritis is a major type of joint disease. Cell therapy is the main hopeful therapeutic method to treat this disorder. The aim of this study was to determine the effect of Scrophularia striata hydroalcoholic extract on the differentiation of human adipose tissue-derived stem cells to chondrogenic and osteogenic cells a perspective for treatment of Osteoarthritis.

Methods

The hydroalcoholic extract of S. striata were prepared. The S. striata extract was standardised according to gallic acid and querctin by HPLC. Human adipose-derived mesenchymal stem cells (hADSCs) were cultured in DMEM/F12 complemented with 10% fetal bovine serum. After the identification of cells, cell viability was measured by MTT assays, 24 and 48 hours after treatment with different concentrations of plant extract. The expression pattern of special chondrogenic and osteogenic genes and stem cell markers was evaluated through real time-PCR.

Results

Our findings showed that the S. striata plant extract has the capability of reducing the viability of hADSCs cells at concentration of 800 and 1000 ug/ml after 24 and 48 hours. The dosage of S. striata that significantly induced hADSCs cell differentiation is IC25, and the IC50 for hADSCs was 865.0 and 642.9 µg/ml after 24 and 48 hours, respectively. The hydroalcoholic extract of the S. striata was standardised according to Gallic acid (0.33 mg gallic acid/g Extract) and Quercetin (2.81 mg quercetin/g Extract) compounds.

Conclusion

The results showed that in addition to exerting anti-inflammatory effects, S. striata can induce the orientation of hADSCs cells into osteogenic and chondrogenic cells.

导言骨关节炎是一种主要的关节疾病。细胞疗法是治疗这种疾病的主要方法。本研究的目的是确定条纹草水醇提取物对人脂肪组织源性干细胞分化为软骨细胞和成骨细胞的影响,为治疗骨关节炎提供一个视角。hADSCs 细胞在添加 10% FBS 的 DMEM/F12 中培养。细胞鉴定后,在使用不同浓度的植物提取物处理 24 和 48 小时后,用 MTT 法检测细胞活力。结果我们的研究结果表明,当 S. striata 植物提取物的浓度为 800 和 1000 ug/ml 时,24 和 48 小时后能降低 hADSCs 细胞的存活率。结果表明,S. striata 除了具有抗炎作用外,还能诱导 hADSCs 细胞定向成骨和软骨细胞。
{"title":"Effect of Scrophularia striata hydroalcoholic extract on differentiation of human adipose-derived mesenchymal stem cells into chondrocytes and osteocytes","authors":"Zahra Bagheri-Hosseinabadi ,&nbsp;Fatemeh Javani Jouni ,&nbsp;Jaber Zafari ,&nbsp;Saba Sadeghi ,&nbsp;Mitra Abbasifard","doi":"10.1016/j.hermed.2023.100841","DOIUrl":"10.1016/j.hermed.2023.100841","url":null,"abstract":"<div><h3>Introduction</h3><p><span><span>Osteoarthritis is a major type of </span>joint disease. Cell therapy is the main hopeful therapeutic method to treat this disorder. The aim of this study was to determine the effect of </span><span><em>Scrophularia</em><em> striata</em></span><span> hydroalcoholic extract on the differentiation of human adipose tissue-derived stem cells to chondrogenic and osteogenic cells a perspective for treatment of Osteoarthritis.</span></p></div><div><h3>Methods</h3><p>The hydroalcoholic extract of <em>S. striata</em> were prepared. The <em>S. striata</em><span><span> extract was standardised according to gallic acid<span> and querctin by HPLC<span><span>. Human adipose-derived mesenchymal stem cells (hADSCs) were cultured in DMEM/F12 complemented with 10% fetal bovine serum. After the identification of cells, </span>cell viability was measured by </span></span></span>MTT assays, 24 and 48 hours after treatment with different concentrations of plant extract. The expression pattern of special chondrogenic and osteogenic genes and stem cell markers was evaluated through real time-PCR.</span></p></div><div><h3>Results</h3><p>Our findings showed that the <em>S. striata</em> plant extract has the capability of reducing the viability of hADSCs cells at concentration of 800 and 1000 ug/ml after 24 and 48 hours. The dosage of <em>S. striata</em> that significantly induced hADSCs cell differentiation is IC25, and the IC50 for hADSCs was 865.0 and 642.9 µg/ml after 24 and 48 hours, respectively. The hydroalcoholic extract of the <em>S. striata</em><span> was standardised according to Gallic acid (0.33 mg gallic acid/g Extract) and Quercetin (2.81 mg quercetin/g Extract) compounds.</span></p></div><div><h3>Conclusion</h3><p>The results showed that in addition to exerting anti-inflammatory effects, <em>S. striata</em> can induce the orientation of hADSCs cells into osteogenic and chondrogenic cells.</p></div>","PeriodicalId":56077,"journal":{"name":"Journal of Herbal Medicine","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2023-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138820966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploration of antidiabetic and antioxidant properties of fresh and freeze-dried Hellenia speciosa, Coccinia grandis and Gymnema sylvestre leaves 新鲜和冷冻干燥的槟榔叶、阔叶木薯叶和麝香草叶的抗糖尿病和抗氧化特性探究
IF 2.3 4区 医学 Q1 Medicine Pub Date : 2023-12-20 DOI: 10.1016/j.hermed.2023.100838
Maheshika Peries , Seneveratne Navartne , Kanchana Abeysekara , Ranil Coorey , Amila Henagamage , Janaka Wijesinghe

Introduction

The drying method can have an impact on the stability and composition of bioactive compounds in plant materials, as well as their therapeutic activities. This study aimed at evaluating the anti-glycation and antioxidant properties of freeze-dried and fresh leaves of selected ayurvedic medicinal plants.

Methods

Fresh and freeze-dried leaves of Hellenia speciosa, Gymnema sylvestre and Coccinia grandis were extracted separately with 95% ethanol. The extracts were studied for their anti-glucosidase, antiglycation, glycation-reversing activities and uptake of glucose by yeast cells. Antioxidant activities of extracts were evaluated using ABTS and DPPH free radical scavenging activities.

Results

All extracts of the freeze-dried leaves showed significant (P < 0.05) anti-glucosidase, antiglycation, and glycation-reversing activities than the fresh leaves of the same species. The freeze-dried leaf extract of H. speciosa demonstrated the highest antiglycation, anti-glucosidase, and glycation reversing activities among the plant species, with IC50 values of 100.76 ± 5.99 µg/ml, 28.11 ± 1.30 µg/ml and EC50 values of 147.24 ± 3.86 µg/ml, respectively. In addition to that, freeze-dried H. speciosa showed the maximum ABTS and DPPH free radical scavenging activity.

Conclusions

This study confirmed that freeze-dried leaves have promising anti-diabetic and antioxidant properties that can be used to develop herbal nutritional supplements or functional foods for diabetes mellitus treatment.

目的 干燥方法会影响植物材料中生物活性化合物的稳定性和组成,并影响其治疗活性。本研究旨在评估冻干和新鲜的精选阿育吠陀药用植物叶片的抗糖化和抗氧化特性。方法用 95% 的乙醇分别提取 Hellenia speciosa、Gymnema sylvestre 和 Coccinia grandis 的新鲜叶片和冻干叶片。研究了提取物的抗糖苷酶、抗糖化、糖化还原活性以及酵母细胞对葡萄糖的吸收。结果所有冻干叶提取物的抗葡萄糖苷酶、抗糖化和糖化还原活性均显著高于同种新鲜叶片(P < 0.05)。在所有植物中,H. speciosa 的冻干叶提取物的抗糖化、抗葡萄糖苷酶和糖化逆转活性最高,IC50 值分别为 100.76 ± 5.99 µg/mL、28.11 ± 1.30 µg/mL,EC50 值为 147.24 ± 3.86 µg/mL。结论 本研究证实,冻干叶片具有良好的抗糖尿病和抗氧化特性,可用于开发治疗糖尿病的草本营养补充剂或功能食品。
{"title":"Exploration of antidiabetic and antioxidant properties of fresh and freeze-dried Hellenia speciosa, Coccinia grandis and Gymnema sylvestre leaves","authors":"Maheshika Peries ,&nbsp;Seneveratne Navartne ,&nbsp;Kanchana Abeysekara ,&nbsp;Ranil Coorey ,&nbsp;Amila Henagamage ,&nbsp;Janaka Wijesinghe","doi":"10.1016/j.hermed.2023.100838","DOIUrl":"10.1016/j.hermed.2023.100838","url":null,"abstract":"<div><h3>Introduction</h3><p>The drying method can have an impact on the stability and composition of bioactive compounds in plant materials, as well as their therapeutic activities. This study aimed at evaluating the anti-glycation and antioxidant properties of freeze-dried and fresh leaves of selected ayurvedic medicinal plants.</p></div><div><h3>Methods</h3><p>Fresh and freeze-dried leaves of <span><em>Hellenia speciosa, </em><em>Gymnema sylvestre</em></span> and <span><em>Coccinia grandis</em></span><span> were extracted separately with 95% ethanol. The extracts were studied for their anti-glucosidase, antiglycation, glycation-reversing activities and uptake of glucose by yeast cells<span><span><span>. Antioxidant activities of extracts were evaluated using </span>ABTS and </span>DPPH<span> free radical scavenging activities.</span></span></span></p></div><div><h3>Results</h3><p>All extracts of the freeze-dried leaves showed significant (<em>P</em> &lt; 0.05) anti-glucosidase, antiglycation, and glycation-reversing activities than the fresh leaves of the same species. The freeze-dried leaf extract of <em>H. speciosa</em><span> demonstrated the highest antiglycation, anti-glucosidase, and glycation reversing activities among the plant species, with IC50 values of 100.76 ± 5.99 µg/ml, 28.11 ± 1.30 µg/ml and EC50 values of 147.24 ± 3.86 µg/ml, respectively. In addition to that, freeze-dried </span><em>H. speciosa</em> showed the maximum ABTS and DPPH free radical scavenging activity.</p></div><div><h3>Conclusions</h3><p>This study confirmed that freeze-dried leaves have promising anti-diabetic and antioxidant properties that can be used to develop herbal nutritional supplements<span><span> or functional foods for diabetes mellitus </span>treatment.</span></p></div>","PeriodicalId":56077,"journal":{"name":"Journal of Herbal Medicine","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2023-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138821413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Monograph on the Use of Herbs to Address Metabolic Syndrome 关于使用草药治疗代谢综合征的专著
IF 2.3 4区 医学 Q1 Medicine Pub Date : 2023-12-19 DOI: 10.1016/j.hermed.2023.100840
R. Lyons

Introduction

Metabolic syndrome is a collection of symptoms that have become an issue on a global scale. While allopathic medicine can address the downstream symptoms, the metabolic pathways that are the root cause of the syndrome can be managed using herbs.

Methods

Criteria for the syndrome were set by the World Health Organization. Suggested herbs are taken from World Health Organization monographs, the British Pharmacopoeia, the United States Pharmacopoeia and the National Formulary, the Ayurvedic Pharmacopoeia, the Pharmacopoeia of the People's Republic of China, and the Japanese Pharmacopoeia. Herbs are cross-referenced with the primary literature when possible. Dietary recommendations and supplements are mentioned tangentially; however, they are not the intended focus of this monograph.

Results

Hyperglycemia is considered a principal component and driver of metabolic syndrome. Insulin resistance, glycolysis, and insulin production can all be affected by herbs. Lipid metabolism occurs primarily in the liver; liver function can be enhanced using herbs. Inflammation caused by a hyperglycemic state can also be managed using herbs and reduced the progression of associated diseases. Since glycolysis and energy production occur in the mitochondria, supporting mitochondrial health with herbs is critical to positively affecting metabolic syndrome.

Conclusions

By using herbs to manage hyperglycemia, inflammation, liver congestion, and mitochondrial health, metabolic syndrome can be slowed, stopped, or even reversed.

简介代谢综合征是一系列症状的集合,已成为全球范围内的一个问题。虽然对抗疗法可以解决下游症状,但作为代谢综合征根源的代谢途径却可以通过草药来控制。建议使用的草药来自世界卫生组织专著、英国药典、美国药典和国家处方集、阿育吠陀药典、中华人民共和国药典和日本药典。草药尽可能与主要文献相互参照。本专著略微提到了饮食建议和补充剂,但它们并不是本专著的重点。结果高血糖被认为是代谢综合征的主要组成部分和驱动因素。胰岛素抵抗、糖酵解和胰岛素分泌都会受到草药的影响。脂质代谢主要发生在肝脏;使用草药可以增强肝功能。高血糖状态引起的炎症也可以通过草药来控制,并减少相关疾病的发展。结论通过使用草药来控制高血糖、炎症、肝脏充血和线粒体健康,可以减缓、阻止甚至逆转代谢综合征。
{"title":"Monograph on the Use of Herbs to Address Metabolic Syndrome","authors":"R. Lyons","doi":"10.1016/j.hermed.2023.100840","DOIUrl":"10.1016/j.hermed.2023.100840","url":null,"abstract":"<div><h3>Introduction</h3><p><span>Metabolic syndrome is a collection of symptoms that have become an issue on a global scale. While </span>allopathic medicine can address the downstream symptoms, the metabolic pathways that are the root cause of the syndrome can be managed using herbs.</p></div><div><h3>Methods</h3><p>Criteria for the syndrome were set by the World Health Organization. Suggested herbs are taken from World Health Organization monographs, the British Pharmacopoeia, the United States Pharmacopoeia and the National Formulary, the Ayurvedic Pharmacopoeia, the Pharmacopoeia of the People's Republic of China, and the Japanese Pharmacopoeia. Herbs are cross-referenced with the primary literature when possible. Dietary recommendations and supplements are mentioned tangentially; however, they are not the intended focus of this monograph.</p></div><div><h3>Results</h3><p><span>Hyperglycemia is considered a principal component and driver of metabolic syndrome. Insulin resistance, glycolysis, and insulin production can all be affected by herbs. </span>Lipid metabolism occurs primarily in the liver; liver function can be enhanced using herbs. Inflammation caused by a hyperglycemic state can also be managed using herbs and reduced the progression of associated diseases. Since glycolysis and energy production occur in the mitochondria, supporting mitochondrial health with herbs is critical to positively affecting metabolic syndrome.</p></div><div><h3>Conclusions</h3><p>By using herbs to manage hyperglycemia, inflammation, liver congestion, and mitochondrial health, metabolic syndrome can be slowed, stopped, or even reversed.</p></div>","PeriodicalId":56077,"journal":{"name":"Journal of Herbal Medicine","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2023-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138992182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Herbal Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1